ImmunogenX
Jack has over 30 years of experience in creating and leading the development of innovative technologies in the analytical instrumentation field. He is regarded as a leading expert in mass spectrometry and trace chemical detection. Previously he founded Syagen Technology, Inc. and led its growth culminating in the successful acquisition in 2011 by the $20B/yr French company Safran.
Jack sits on the Board of Directors of Flamentera AG, Advanced Telesensors, PhageTech, Analytical Detection, and Appellation Ventures. Jack has published over 130 papers, delivered about 100 invited talks, has over 30 U.S. patents issued or pending, and appears on the list of the Most Highly Cited Chemists.
His honorary positions include Fellow of the American Physical Society, Visiting Professor at UC Irvine, Visiting Professor at the Université de Paris-Sud, Editorial Board member of the Journal of Physical Chemistry, and invitee to the Nobel Symposium in Chemistry. He has received a Tibbets Award (SBIR) and was recently inducted into the Orange County OC 500 Directory of Influence. He received BA and PhD degrees from Hamilton College and Brown University, respectively, where he won several academic awards including Best Thesis. He was a postdoctoral fellow at Caltech under Nobel Laureate Ahmed Zewail.
This person is not in any offices
ImmunogenX
ImmunogenX is a clinical-stage company founded in 2013 and supported by a team of world-renowned scientists and collaborators. ImmunogenX was formed to address critical needs for individuals with suspected or diagnosed celiac disease.